Caffeine and related xanthines can have significant behavioral effects
on measures of locomotor activity, schedule-controlled behavior, drug
self-administration, and learning and memory. Xanthines also produce
numerous physiological effects including positive inotropic and chrono
tropic effects on the heart, decreased airway resistance in the lung,
and respiratory stimulation. Due to the widespread use of xanthines as
constituents of food and beverages and as therapeutic drugs, identifi
cation of mechanisms that mediate their pharmacological effects has co
nsiderable relevance for drug development and therapeutics. Two primar
y mechanisms involving the cyclic nucleotide system have been implicat
ed as the bases for the effects of xanthines in the CNS. Many xanthine
s bind to specific adenosine recognition sites and block the actions o
f adenosine. Xanthines also inhibit cyclic nucleotide phosphodiesteras
es, the enzymes responsible for the hydrolytic inactivation of cyclic
AMP and cyclic GMP. Recent research in nonhuman primates has character
ized the behavioral, respiratory and cardiovascular effects of a numbe
r of xanthines and related drugs differing in affinity at different su
btypes of adenosine receptors and in capacity to inhibit different mol
ecular forms of PDE. The behavioral-stimulant effects of xanthines app
ear to be mediated principally by their adenosine-antagonist actions a
nd may be limited by PDE inhibition. The respiratory-stimulant and car
diac effects of xanthines, on the other hand, appear to be linked more
closely to their PDE-inhibiting actions than to adenosine antagonism.
Converging lines of evidence suggest that adenosine A(2) and cAMP-spe
cific (possibly type IV) PDE mechanisms play especially prominent role
s in mediating the behavioral and physiological effects of xanthines i
n nonhuman primates.